Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biological response modifiers: the new immunotherapy.

× No keyword cloud information.

44 in total

Review 1. The cytokines are coming.

Authors: K P Windebank
Journal: Arch Dis Child Date: 1990-11 Impact factor: 3.791

2. [Janus-faced character of chemotherapy: a comment on the Abel theses].

Authors: D Schmähl
Journal: Klin Wochenschr Date: 1991-01-04

3. Growth suppression of transformed cells by a human placental extract not related to transforming growth factor beta.

Authors: J L Klein; E Hamel; J L Tayot; H Yamasaki
Journal: J Cancer Res Clin Oncol Date: 1991 Impact factor: 4.553

Review 4. Graft versus leukemia.

Authors: A Butturini; R P Gale
Journal: Immunol Res Date: 1992 Impact factor: 2.829

5. Recombinant interleukin-2 treatment in patients with metastatic colorectal cancer: effect on natural cytotoxicity.

Authors: K G Park; S D Heys; J B Murray; P D Hayes; J A Ashby; C R Franks; O Eremin
Journal: Cancer Immunol Immunother Date: 1992 Impact factor: 6.968

Review 6. Magnetic nanoparticles in MR imaging and drug delivery.

Authors: Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal: Adv Drug Deliv Rev Date: 2008-04-10 Impact factor: 15.470

Review 7. Rationale for immunotherapy of renal cell carcinoma.

Authors: R Heicappell; R Ackermann
Journal: Urol Res Date: 1990

8. Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.

Authors: Z Gazit; D W Weiss; D Shouval; M Yechezkeli; V Schirrmacher; M Notter; J Walter; E Kedar
Journal: Cancer Immunol Immunother Date: 1992 Impact factor: 6.968

9. Activated monocytes kill malignant brain tumor cells in vitro.

Authors: M Kirsch; H Fischer; G Schackert
Journal: J Neurooncol Date: 1994 Impact factor: 4.130

10. Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors.

Authors: G Gasparini; S Dal Fior; F Pozza; G A Panizzoni; S Favretto; D D Von Hoff
Journal: Invest New Drugs Date: 1991-08 Impact factor: 3.850